Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
Invest New Drugs
; 40(1): 209-214, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34398354
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Small Cell Lung Carcinoma
/
Antibodies, Monoclonal, Humanized
/
Immune Checkpoint Inhibitors
/
Anaphylaxis
/
Lung Neoplasms
Limits:
Aged
/
Humans
/
Male
Language:
En
Year:
2022
Type:
Article